Rocuronium Bromide Injection, Solution
Product Images NDC 43066-509

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 43066-509). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10ml-mono-carton (10ml Mono Carton)

Label for Rocuronium Bromide Injection 100 mg/10 mL (10 mg/mL) solution for intravenous use. The package contains a single 10 mL pre-filled syringe. Manufactured for Baxter Healthcare Corporation and by Gland Pharma Limited. Warning states it is a paralyzing agent causing respiratory arrest and requires facilities for artificial respiration. Storage instructions and ingredients are also included.*

FDA Label Image

10ml-outer-carton (10ml Outer Carton)

Packaging label for Rocuronium Bromide Injection, 100 mg/10 mL (10 mg/mL) solution for intravenous use. The label includes a warning about respiratory arrest and mandates availability of artificial respiration facilities. It indicates 5 x 10 mL single-dose pre-filled syringes. Manufactured by Baxter Healthcare Corporation in the USA and Gland Pharma Limited in India.*

FDA Label Image

10ml-pfs-label (10ml Pfs Label)

Label for Rocuronium Bromide Injection, 100 mg/10 mL (10 mg/mL) solution for intravenous use. The label includes dosing information, storage instructions to keep refrigerated at 2°C to 8°C and warnings about respiratory arrest and artificial respiration requirements. It also specifies the product is sterile, nonpyrogenic, supplied as a 10 mL single-dose pre-filled syringe, and manufactured by Baxter Healthcare Corporation.*

FDA Label Image

5ml-mono-carton (5ml Mono Carton)

Packaging label for Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) by Baxter Healthcare Corporation. The label indicates intravenous use and includes warnings about paralysis and respiratory arrest. It specifies a single-dose pre-filled syringe of 5 mL. Manufacturer details list Gland Pharma Limited in India and Baxter Healthcare Corporation, USA. Additional storage and safety information is also present.*

FDA Label Image

5ml-outer-carton (5ml Outer Carton)

Packaging label for Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) by Baxter Healthcare Corporation. The label indicates the product is for intravenous use only, provided as 5 single-dose pre-filled syringes of 5 mL each. It includes a warning about respiratory arrest and the need for immediate availability of artificial respiration.*

FDA Label Image

5ml-pfs-label (5ml Pfs Label)

Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) intravenous solution label. It includes a warning that it is a paralyzing agent causing respiratory arrest, requiring immediate availability of artificial respiration. The label specifies storage instructions, usage for intravenous injection, and indicates the product is supplied in a 5 mL single-dose pre-filled syringe by Baxter Healthcare Corporation.*

FDA Label Image

10ml-pfs-figure (Figure 1 10ml)

A black-and-white diagram of a 10 mL syringe with clear graduations marking each milliliter from 0 to 10. The syringe includes a plunger and a cap over the needle end, illustrating a typical intravenous injection device.*

FDA Label Image

5ml-pfs-figure (Figure 1 5ml)

An illustration of a 5 mL syringe with a black cap on the tip, clear barrel marked with a 5 mL scale, gray plunger inside, and white plunger handle. The syringe is shown horizontally with measurement markings visible from 0 to 5 mL.*

FDA Label Image

Pfs-tip-remove-figure (Figure 2)

A black and white instructional illustration showing two hands assembling or attaching a small nozzle or cap to the end of a cylindrical tube. An arrow indicates the direction of attachment, suggesting the proper technique for connecting the components, likely related to the preparation or administration of Rocuronium Bromide injection solution.*

FDA Label Image

Figure 1 (Rocuronium Function of Dose)

A scatter and box plot chart displaying time in minutes on the y-axis against Rocuronium Bromide dose in mg/kg by age groups on the x-axis. Age groups include 18-64 years, 65 years and older, and 1-12 years, with various dose levels plotted for each group. The chart shows data points and distribution ranges for Rocuronium Bromide intravenous injection dosage timing.*

FDA Label Image

Figure 2 (Rocuronium Function of Dose)

A scatter plot with box plots showing the distribution of a variable measured in minutes on the y-axis across different groups denoted by a numeric scale on the x-axis, likely representing doses or time intervals. Data points vary widely within each group, indicating variability in the measurement over the defined categories.*

FDA Label Image

Figure 3 (Rocuronium Clinical Durations)

A line graph showing the relationship between dose number and time in minutes for Rocuronium Bromide at two different doses: 0.1 mg/kg and 0.15 mg/kg. The graph includes data points for each dose number from 1 to 5, with time increasing for both doses. Sample sizes (N) are indicated as 29 for 0.1 mg/kg and 13 for 0.15 mg/kg.*

FDA Label Image

Rocuronium-structural-formula (Rocuronium Structural Formula)

Chemical structure of rocuronium bromide, a steroidal neuromuscular blocking agent. The diagram shows its molecular configuration including multiple ring systems, functional groups, and the bromide ion (Br-).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.